SCHEMBL7973344

SCHEMBL7973344

CCOC(=O)c1nn(Cc2ccc(OC)cc2)c(-c2ccccc2)c1OCc1ccc(OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.53
MAPT P10636 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 1/20 0.46
ALDH1A1 P00352 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
MAOB P27338 1/20 0.45
LMNA P02545 1/20 0.45
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
KDM4E B2RXH2 1/20 0.44
USP2 O75604 1/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
MAPK1 P28482 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20307720 0.92 CYP19A1 (0.63) CYP19A1MAPTSMN1; SMN2POLBALDH1A1
SCHEMBL7977426 0.89 CNR1 (0.48) MAPTSMN1; SMN2POLBALDH1A1LMNA
SCHEMBL10140271 0.88 CNR1 (0.47) MAPTSMN1; SMN2POLBALDH1A1NPSR1
SCHEMBL10140554 0.85 ALDH1A1 (0.43) CYP19A1MAPTSMN1; SMN2POLBALDH1A1
SCHEMBL16258926 0.83 CYP19A1 (0.60) CYP19A1MAPTSMN1; SMN2POLBALDH1A1
SCHEMBL3793270 0.75 MAPT (0.51) CYP19A1MAPTSMN1; SMN2ALDH1A1NPSR1
SCHEMBL25307190 0.75 ALDH1A1 (0.58) MAPTSMN1; SMN2POLBALDH1A1LMNA
SCHEMBL10140278 0.74 SMN1; SMN2 (0.48) SMN1; SMN2POLBNPSR1CNR1CNR2
SCHEMBL16377892 0.73 PTGER4 (0.56) MAPTSMN1; SMN2POLBALDH1A1CNR1
SCHEMBL9925003 0.73 PTGDR2 (0.54) MAPTSMN1; SMN2POLBALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2805939-B1 Heterocyclic compounds as factor IXA inhibitors. MERCK SHARP & DOHME (US) 2018-06-27 EP disclosed
EP-2805939-A1 Heterocyclic compounds as factor IXA inhibitors. Merck Sharp & Dohme Corp. (US) 2014-11-26 EP disclosed
WO-2009143039-A2 HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2009-11-26 WO disclosed